Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings.

European heart journal. Acute cardiovascular care

Juthier F, Ennezat PV, Fornes P, Hachulla E, Hatron PY, Robin E, Prat A, Bouchindhomme B, Banfi C, Fouquet O, Vincentelli A.
PMID: 24062914
Eur Heart J Acute Cardiovasc Care. 2012 Sep;1(3):248-52. doi: 10.1177/2048872612455142.

This case vignette relates the unknown association between systemic capillary leak syndrome, namely Clarkson's syndrome, and acute cardiac dysfunction. 'Central extra-corporeal life support (ECLS)' was needed for the management of an intractable cardiogenic shock. The acute cardiac condition completely...

Cite
Juthier F, Ennezat PV, Fornes P, et al. Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings. Eur Heart J Acute Cardiovasc Care. 2012;1(3):248-52doi: 10.1177/2048872612455142.
Juthier, F., Ennezat, P. V., Fornes, P., Hachulla, E., Hatron, P. Y., Robin, E., Prat, A., Bouchindhomme, B., Banfi, C., Fouquet, O., & Vincentelli, A. (2012). Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings. European heart journal. Acute cardiovascular care, 1(3), 248-52. https://doi.org/10.1177/2048872612455142
Juthier, Francis, et al. "Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings." European heart journal. Acute cardiovascular care vol. 1,3 (2012): 248-52. doi: https://doi.org/10.1177/2048872612455142
Juthier F, Ennezat PV, Fornes P, Hachulla E, Hatron PY, Robin E, Prat A, Bouchindhomme B, Banfi C, Fouquet O, Vincentelli A. Myocardial involvement in systemic capillary leak syndrome: first demonstration by pathologic findings. Eur Heart J Acute Cardiovasc Care. 2012 Sep;1(3):248-52. doi: 10.1177/2048872612455142. PMID: 24062914; PMCID: PMC3760545.
Copy Download .nbib Format: NLM
Antiphospholipid syndrome: state of the art on clinical practice guidelines.

RMD open

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.
PMID: 30402272
RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN...

Cite
Limper M, Scirè CA, Talarico R, et al. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000785doi: 10.1136/rmdopen-2018-000785.
Limper, M., Scirè, C. A., Talarico, R., Amoura, Z., Avcin, T., Basile, M., Burmester, G., Carli, L., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Dörner, T., Fonseca, J. E., Galetti, I., Hachulla, E., Launay, D., Lourenco, F., Macieira, C., Meroni, P., Montecucco, C. M., Moraes-Fontes, M. F., Mouthon, L., Nalli, C., Ramoni, V., Tektonidou, M., van Laar, J. M., Bombardieri, S., Schneider, M., Smith, V., Vieira, A., Cutolo, M., Mosca, M., & Tincani, A. (2018). Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD open, 4e000785. https://doi.org/10.1136/rmdopen-2018-000785
Limper, Marteen, et al. "Antiphospholipid syndrome: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000785. doi: https://doi.org/10.1136/rmdopen-2018-000785
Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018. PMID: 30402272; PMCID: PMC6203101.
Copy Download .nbib Format: NLM
Sjögren's syndrome: state of the art on clinical practice guidelines.

RMD open

Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X.
PMID: 30402274
RMD Open. 2018 Oct 18;4:e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018.

Sjögren's syndrome (SS) is a complex autoimmune rheumatic disease that specifically targets salivary and lachrymal glands. As such, patients typically had ocular and oral dryness and salivary gland swelling. Moreover, skin, nasal and vaginal dryness are frequently present. In...

Cite
Romão VC, Talarico R, Scirè CA, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000789doi: 10.1136/rmdopen-2018-000789.
Romão, V. C., Talarico, R., Scirè, C. A., Vieira, A., Alexander, T., Baldini, C., Gottenberg, J. E., Gruner, H., Hachulla, E., Mouthon, L., Orlandi, M., Pamfil, C., Pineton de Chambrun, M., Taglietti, M., Toplak, N., van Daele, P., van Laar, J. M., Bombardieri, S., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Mariette, X. (2018). Sjögren's syndrome: state of the art on clinical practice guidelines. RMD open, 4e000789. https://doi.org/10.1136/rmdopen-2018-000789
Romão, Vasco C, et al. "Sjögren's syndrome: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000789. doi: https://doi.org/10.1136/rmdopen-2018-000789
Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018. PMID: 30402274; PMCID: PMC6203093.
Copy Download .nbib Format: NLM
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.

Rheumatology (Oxford, England)

Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH.
PMID: 29635517
Rheumatology (Oxford). 2018 Jul 01;57(7):1299-1304. doi: 10.1093/rheumatology/key090.

OBJECTIVE: To identify biomarkers of articular and ocular disease activity in patients with Blau syndrome (BS).METHODS: Multiplex plasma protein arrays were performed in five BS patients and eight normal healthy volunteers (NHVs). Plasma S100A12 and S100A8/9 were subsequently measured...

Cite
Wang L, Rosé CD, Foley KP, et al. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford). 2018;57(7):1299-1304doi: 10.1093/rheumatology/key090.
Wang, L., Rosé, C. D., Foley, K. P., Anton, J., Bader-Meunier, B., Brissaud, P., Chédeville, G., Cimaz, R., Fernández-Martín, J., Guly, C., Hachulla, E., Harjacek, M., Mackensen, F., Merino, R., Modesto, C., Naranjo Hernández, A., Pajot, C., Ramanan, A. V., Thatayatikom, A., Thomée, C., Vastert, S., Votta, B. J., Bertin, J., & Wouters, C. H. (2018). S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford, England), 57(7), 1299-1304. https://doi.org/10.1093/rheumatology/key090
Wang, Lin, et al. "S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome." Rheumatology (Oxford, England) vol. 57,7 (2018): 1299-1304. doi: https://doi.org/10.1093/rheumatology/key090
Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford). 2018 Jul 01;57(7):1299-1304. doi: 10.1093/rheumatology/key090. PMID: 29635517.
Copy Download .nbib Format: NLM
Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases.

Journal of clinical medicine

Boursier G, Rittore C, Georgin-Lavialle S, Belot A, Galeotti C, Hachulla E, Hentgen V, Rossi-Semerano L, Sarrabay G, Touitou I.
PMID: 31635385
J Clin Med. 2019 Oct 18;8(10). doi: 10.3390/jcm8101729.

Monogenic autoinflammatory diseases (AIDs) are caused by variants in genes that regulate innate immunity. The current diagnostic performance of targeted next-generation sequencing (NGS) for AIDs is low. We assessed whether pre-analytic advice from expert clinicians could help improve NGS...

Cite
Boursier G, Rittore C, Georgin-Lavialle S, et al. Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases. J Clin Med. 2019;8(10)doi: 10.3390/jcm8101729.
Boursier, G., Rittore, C., Georgin-Lavialle, S., Belot, A., Galeotti, C., Hachulla, E., Hentgen, V., Rossi-Semerano, L., Sarrabay, G., & Touitou, I. (2019). Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases. Journal of clinical medicine, 8(10), . https://doi.org/10.3390/jcm8101729
Boursier, Guilaine, et al. "Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases." Journal of clinical medicine vol. 8,10 (2019). doi: https://doi.org/10.3390/jcm8101729
Boursier G, Rittore C, Georgin-Lavialle S, Belot A, Galeotti C, Hachulla E, Hentgen V, Rossi-Semerano L, Sarrabay G, Touitou I. Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases. J Clin Med. 2019 Oct 18;8(10). doi: 10.3390/jcm8101729. PMID: 31635385; PMCID: PMC6832712.
Copy Download .nbib Format: NLM
Incidental diagnosis of a silent brachiocephalic vein aneurysm and its surgical treatment.

Journal of vascular surgery cases and innovative techniques

Yilmaz N, Pelouze A, Murith N, Hachulla AL, Huber C, Cikirikcioglu M.
PMID: 32055757
J Vasc Surg Cases Innov Tech. 2020 Feb 04;6(1):21-23. doi: 10.1016/j.jvscit.2019.11.010. eCollection 2020 Mar.

Brachiocephalic vein aneurysm is an extremely rare clinical entity, with a limited number of case reports in the literature. We report the case of a 74-year-old woman with a left brachiocephalic vein aneurysm (3 × 3 × 6.5 cm)...

Cite
Yilmaz N, Pelouze A, Murith N, et al. Incidental diagnosis of a silent brachiocephalic vein aneurysm and its surgical treatment. J Vasc Surg Cases Innov Tech. 2020;6(1):21-23doi: 10.1016/j.jvscit.2019.11.010.
Yilmaz, N., Pelouze, A., Murith, N., Hachulla, A. L., Huber, C., & Cikirikcioglu, M. (2020). Incidental diagnosis of a silent brachiocephalic vein aneurysm and its surgical treatment. Journal of vascular surgery cases and innovative techniques, 6(1), 21-23. https://doi.org/10.1016/j.jvscit.2019.11.010
Yilmaz, Nurcan, et al. "Incidental diagnosis of a silent brachiocephalic vein aneurysm and its surgical treatment." Journal of vascular surgery cases and innovative techniques vol. 6,1 (2020): 21-23. doi: https://doi.org/10.1016/j.jvscit.2019.11.010
Yilmaz N, Pelouze A, Murith N, Hachulla AL, Huber C, Cikirikcioglu M. Incidental diagnosis of a silent brachiocephalic vein aneurysm and its surgical treatment. J Vasc Surg Cases Innov Tech. 2020 Feb 04;6(1):21-23. doi: 10.1016/j.jvscit.2019.11.010. eCollection 2020 Mar. PMID: 32055757; PMCID: PMC7005478.
Copy Download .nbib Format: NLM
Systemic lupus erythematosus: state of the art on clinical practice guidelines.

RMD open

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
PMID: 30564454
RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018.

Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-remitting course. The aim of the present work was to identify current available clinical practice guidelines (CPGs)...

Cite
Tamirou F, Arnaud L, Talarico R, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793doi: 10.1136/rmdopen-2018-000793.
Tamirou, F., Arnaud, L., Talarico, R., Scirè, C. A., Alexander, T., Amoura, Z., Avcin, T., Bortoluzzi, A., Cervera, R., Conti, F., Cornet, A., Devilliers, H., Doria, A., Frassi, M., Fredi, M., Govoni, M., Houssiau, F., Lladò, A., Macieira, C., Martin, T., Massaro, L., Moraes-Fontes, M. F., Pamfil, C., Paolino, S., Tani, C., Tas, S. W., Tektonidou, M., Tincani, A., Van Vollenhoven, R. F., Bombardieri, S., Burmester, G., Eurico, F. J., Galetti, I., Hachulla, E., Mueller-Ladner, U., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Costedoat-Chalumeau, N. (2018). Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD open, 4(2), e000793. https://doi.org/10.1136/rmdopen-2018-000793
Tamirou, Farah, et al. "Systemic lupus erythematosus: state of the art on clinical practice guidelines." RMD open vol. 4,2 (2018): e000793. doi: https://doi.org/10.1136/rmdopen-2018-000793
Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. PMID: 30564454; PMCID: PMC6269635.
Copy Download .nbib Format: NLM
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.

Annals of the rheumatic diseases

Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C, Hachulla E, Veillard E, Strakova E, Burmester GR, Yardımcı GK, Gomez-Puerta JA, Zepa J, Kearsley-Fleet L, Trefond L, Cunha M, Mosca M, Cornalba M, Soubrier M, Roux N, Brocq O, Durez P, Conway R, Goulenok T, Bijlsma JW, McInnes IB, Mariette X.
PMID: 34972811
Ann Rheum Dis. 2021 Dec 31; doi: 10.1136/annrheumdis-2021-221490. Epub 2021 Dec 31.

OBJECTIVES: To describe the safety of vaccines against SARS-CoV-2 in people with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD).METHODS: Physician-reported registry of I-RMD and non-inflammatory RMD (NI-RMDs) patients vaccinated against SARS-CoV-2. From 5 February 2021 to 27 July 2021, we...

Cite
Machado PM, Lawson-Tovey S, Strangfeld A, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. 2021;doi: 10.1136/annrheumdis-2021-221490.
Machado, P. M., Lawson-Tovey, S., Strangfeld, A., Mateus, E. F., Hyrich, K. L., Gossec, L., Carmona, L., Rodrigues, A., Raffeiner, B., Duarte, C., Hachulla, E., Veillard, E., Strakova, E., Burmester, G. R., Yardımcı, G. K., Gomez-Puerta, J. A., Zepa, J., Kearsley-Fleet, L., Trefond, L., Cunha, M., Mosca, M., Cornalba, M., Soubrier, M., Roux, N., Brocq, O., Durez, P., Conway, R., Goulenok, T., Bijlsma, J. W., McInnes, I. B., & Mariette, X. (2021). Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2021-221490
Machado, Pedro M, et al. "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry." Annals of the rheumatic diseases vol. (2021). doi: https://doi.org/10.1136/annrheumdis-2021-221490
Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Rodrigues A, Raffeiner B, Duarte C, Hachulla E, Veillard E, Strakova E, Burmester GR, Yardımcı GK, Gomez-Puerta JA, Zepa J, Kearsley-Fleet L, Trefond L, Cunha M, Mosca M, Cornalba M, Soubrier M, Roux N, Brocq O, Durez P, Conway R, Goulenok T, Bijlsma JW, McInnes IB, Mariette X. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. 2021 Dec 31; doi: 10.1136/annrheumdis-2021-221490. Epub 2021 Dec 31. PMID: 34972811; PMCID: PMC8720639.
Copy Download .nbib Format: NLM
[Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema].

La Revue de medecine interne

Nicolas A, Launay D, Duprez C, Citerne I, Morell-Dubois S, Sobanski V, Hachulla É, Staumont-Sallé D, Farhat MM, Sanges S.
PMID: 34158189
Rev Med Interne. 2021 Sep;42(9):608-615. doi: 10.1016/j.revmed.2021.05.013. Epub 2021 Jun 20.

INTRODUCTION: Hereditary angioedema (HAE) is characterized by recurrent attacks of swelling of various locations and severity. An impaired quality of life of patients with HAE has been reported by several studies. We aimed at examining the overall impact of...

Cite
Nicolas A, Launay D, Duprez C, et al. Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients. [Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema]. Rev Med Interne. 2021;42(9):608-615doi: 10.1016/j.revmed.2021.05.013.
Nicolas, A., Launay, D., Duprez, C., Citerne, I., Morell-Dubois, S., Sobanski, V., Hachulla, �. �., Staumont-Sallé, D., Farhat, M. M., & Sanges, S. (2021). Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients. [Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema]. La Revue de medecine interne, 42(9), 608-615. https://doi.org/10.1016/j.revmed.2021.05.013
Nicolas, A, et al. "Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients." [Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema]. La Revue de medecine interne vol. 42,9 (2021): 608-615. doi: https://doi.org/10.1016/j.revmed.2021.05.013
Nicolas A, Launay D, Duprez C, Citerne I, Morell-Dubois S, Sobanski V, Hachulla É, Staumont-Sallé D, Farhat MM, Sanges S. Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients. [Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema]. Rev Med Interne. 2021 Sep;42(9):608-615. doi: 10.1016/j.revmed.2021.05.013. Epub 2021 Jun 20. French. PMID: 34158189.
Copy Download .nbib Format: NLM
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience.

Blood advances

Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, Balsat M, Scanvion Q, Hachulla E, Launay D, Yakoub-Agha I, Terriou L.
PMID: 34714914
Blood Adv. 2021 Oct 29; doi: 10.1182/bloodadvances.2021004749. Epub 2021 Oct 29.

The recently described VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by somatic mutations in UBA1. Patients with VEXAS display late-onset autoinflammatory symptoms, usually refractory to treatment, and hematologic abnormalities. The identification of an easily-accessible specific marker...

Cite
Diarra A, Duployez N, Fournier E, et al. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021004749.
Diarra, A., Duployez, N., Fournier, E., Preudhomme, C., Coiteux, V., Magro, L., Quesnel, B., Heiblig, M., Sujobert, P., Barraco, F., Balsat, M., Scanvion, Q., Hachulla, E., Launay, D., Yakoub-Agha, I., & Terriou, L. (2021). Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience. Blood advances, . https://doi.org/10.1182/bloodadvances.2021004749
Diarra, Ava, et al. "Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021004749
Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, Balsat M, Scanvion Q, Hachulla E, Launay D, Yakoub-Agha I, Terriou L. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a two center experience. Blood Adv. 2021 Oct 29; doi: 10.1182/bloodadvances.2021004749. Epub 2021 Oct 29. PMID: 34714914.
Copy Download .nbib Format: NLM
Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team.

Diagnostics (Basel, Switzerland)

Coirier V, Chabanne C, Jouneau S, Belhomme N, Ballerie A, Cazalets C, Sobanski V, Hachulla É, Jégo P, Lescoat A.
PMID: 34679436
Diagnostics (Basel). 2021 Sep 22;11(10). doi: 10.3390/diagnostics11101738.

BACKGROUND: to compare three existing screening algorithms of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) with the results of a multidisciplinary team (MDT) meeting from a tertiary center.METHODS: we conducted a monocentric longitudinal study from 2015 to 2018....

Cite
Coirier V, Chabanne C, Jouneau S, et al. Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team. Diagnostics (Basel). 2021;11(10)doi: 10.3390/diagnostics11101738.
Coirier, V., Chabanne, C., Jouneau, S., Belhomme, N., Ballerie, A., Cazalets, C., Sobanski, V., Hachulla, �. �., Jégo, P., & Lescoat, A. (2021). Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team. Diagnostics (Basel, Switzerland), 11(10), . https://doi.org/10.3390/diagnostics11101738
Coirier, Valentin, et al. "Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team." Diagnostics (Basel, Switzerland) vol. 11,10 (2021). doi: https://doi.org/10.3390/diagnostics11101738
Coirier V, Chabanne C, Jouneau S, Belhomme N, Ballerie A, Cazalets C, Sobanski V, Hachulla É, Jégo P, Lescoat A. Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team. Diagnostics (Basel). 2021 Sep 22;11(10). doi: 10.3390/diagnostics11101738. PMID: 34679436; PMCID: PMC8534432.
Copy Download .nbib Format: NLM
"Double-Parachute" Mitral Valve.

JACC. Case reports

Minetto D, Blanche C, Hachulla AL, Sologashvili T, Meyer P.
PMID: 34317218
JACC Case Rep. 2020 Jan 08;2(2):261-265. doi: 10.1016/j.jaccas.2019.11.032. eCollection 2020 Feb.

A 38-year-old asymptomatic man was referred by his general practitioner for a 3/6 systolic heart murmur, which was detected during a routine consultation. Echocardiography revealed a parachute mitral valve associated with a parachute-like membrane, causing significant subaortic obstruction that...

Cite
Minetto D, Blanche C, Hachulla AL, et al. "Double-Parachute" Mitral Valve. JACC Case Rep. 2020;2(2):261-265doi: 10.1016/j.jaccas.2019.11.032.
Minetto, D., Blanche, C., Hachulla, A. L., Sologashvili, T., & Meyer, P. (2020). "Double-Parachute" Mitral Valve. JACC. Case reports, 2(2), 261-265. https://doi.org/10.1016/j.jaccas.2019.11.032
Minetto, Dany, et al. ""Double-Parachute" Mitral Valve." JACC. Case reports vol. 2,2 (2020): 261-265. doi: https://doi.org/10.1016/j.jaccas.2019.11.032
Minetto D, Blanche C, Hachulla AL, Sologashvili T, Meyer P. "Double-Parachute" Mitral Valve. JACC Case Rep. 2020 Jan 08;2(2):261-265. doi: 10.1016/j.jaccas.2019.11.032. eCollection 2020 Feb. PMID: 34317218; PMCID: PMC8298313.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries